{"Symbol": "INCY", "AssetType": "Common Stock", "Name": "Incyte Corporation", "Description": "Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.", "CIK": "879169", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "TRADE & SERVICES", "Industry": "SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH", "Address": "1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, US", "OfficialSite": "https://www.incyte.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "11265071000", "EBITDA": "177597000", "PERatio": "382.53", "PEGRatio": "0.367", "BookValue": "17.82", "DividendPerShare": "None", "DividendYield": "None", "EPS": "0.15", "RevenuePerShareTTM": "20.48", "ProfitMargin": "0.0077", "OperatingMarginTTM": "0.253", "ReturnOnAssetsTTM": "0.0086", "ReturnOnEquityTTM": "0.0075", "RevenueTTM": "4241217000", "GrossProfitTTM": "1484626000", "DilutedEPSTTM": "0.15", "QuarterlyEarningsGrowthYOY": "0.143", "QuarterlyRevenueGrowthYOY": "0.163", "AnalystTargetPrice": "73.31", "AnalystRatingStrongBuy": "2", "AnalystRatingBuy": "8", "AnalystRatingHold": "16", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "1", "TrailingPE": "382.53", "ForwardPE": "9.49", "PriceToSalesRatioTTM": "2.656", "PriceToBookRatio": "3.221", "EVToRevenue": "2.12", "EVToEBITDA": "22.03", "Beta": "0.898", "52WeekHigh": "83.95", "52WeekLow": "50.35", "50DayMovingAverage": "64.93", "200DayMovingAverage": "67.65", "SharesOutstanding": "193524000", "DividendDate": "None", "ExDividendDate": "None"}